Development of PCL/PEO electrospun fibrous membranes blended with silane-modified halloysite nanotube as a curcumin release system
Source abstract
Abstract
Abstract In this work, electrospun fibrous membranes based on the polycaprolactone (PCL)/polyethylene oxide (PEO) blended with pure, 3-Aminopropyltriethoxysilane (APTES) or 3-Glycidoxypropyltrimethoxysilane (GPTMS) modified halloysite nanotubes (HNT) were prepared by electrospinning for curcumin (Cur) delivery system. The morphological and physicochemical properties of the fabricated membranes were characterized by scanning electron microscopy (SEM), atomic force microscopy (AFM), Fourier transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD). In vitro release of from the Cur loaded fibrous membranes was examined in simulated physiological condition by ultraviolet–visible spectroscopy. Besides, in vitro cytotoxicity on the MCF-7 breast carcinoma cells was evaluated. The results demonstrated that the silane-modified HNTs (HNT-APTES and HNT-GPTMS) displayed a much higher Cur loading capacity while APTES modified HNT had the maximum encapsulation efficiency. Moreover, in vitro Cur release studies demonstrated that PCL/PEO-Cur/HNT-APTES membrane has a slower release profile. The release mechanism of Cur from all membranes was fitted by the Peppas-Sahlin kinetic model indicating a pseudo-Fickian and non-Fickian release. Additionally, the PCL/PEO-Cur/HNT-APTES membrane showed the highest toxicity against MCF-7 breast cancer cells. In conclusion, the uses of this Cur loaded PCL/PEO electrospun fibrous membranes blended with the APTES modified HNT can be used to loading of other drugs for controlled drug delivery system, especially as an anticancer carrier.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Clay minerals and soil interactions · Nanoparticle-Based Drug Delivery · Therapeutic Uses of Natural Elements
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Halloysite clay nanotubes as a ceramic “skeleton” for functional biopolymer composites with sustained drug release10.1039/c3tb20059k ↗
2. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases10.1016/j.biocel.2008.06.010 ↗
3. Use of clays as drug delivery systems: Possibilities and limitations10.1016/j.clay.2006.06.015 ↗
4. Release kinetics of 5-aminosalicylic acid from halloysite10.1016/j.colsurfb.2012.12.041 ↗
5. Fabrication of Curcumin-loaded Gliadin Electrospun Nanofibrous Structures and Bioactive Properties10.1007/s12221-019-8950-8 ↗
6. Bioavailability of curcumin: Problems and promises10.1021/mp700113r ↗
7. Quercetin/β-cyclodextrin inclusion complex embedded nanofibres: Slow release and high solubility10.1016/j.foodchem.2015.11.051 ↗
8. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake10.1016/j.ejpb.2017.04.013 ↗
9. Production, characterization and testing of antibacterial PVA membranes loaded with HA-Ag 3 PO 4 nanoparticles, produced by SC-CO 2 phase inversion10.1002/jctb.5749 ↗
10. Multi-walled carbon nanotube-incorporating electrospun composite fibrous mats for controlled drug release profile10.1016/j.ijpharm.2019.118513 ↗
11. Preparation and properties of nanodiamond/poly(lactic acid) composite nanofiber scaffolds10.1007/s12221-014-2544-2 ↗
12. Preparation and physical, thermal properties of polycaprolactone / m-Halloysite nanocomposite
13. The effects of silane coupling agents on the properties of PHBV/halloysite nanocomposites10.1016/j.clay.2013.11.032 ↗
14. Surface modification of halloysite nanotubes with dopamine for enzyme immobilization10.1021/am4022973 ↗
15. Dexamethasone loaded core-shell SF/PEO nanofibers via green electrospinning reduced endothelial cells inflammatory damage10.1016/j.colsurfb.2014.09.016 ↗
16. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments10.1007/s13167-010-0001-x ↗
17. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
18. Polymeric modification and its implication in drug delivery: Poly-ε-caprolactone (PCL) as a model polymer10.1021/mp3001952 ↗
19. Kinetic modeling on drug release from controlled drug delivery systems
20. Applications of poly(ethylene oxide) in drug delivery systems: Part II
21. Chemopreventive and therapeutic effects of curcumin10.1016/j.canlet.2004.09.041 ↗
22. Quercetin-loaded and unloaded electrospun membranes: Synthesis, characterization and in vitro release study10.1016/j.jddst.2018.06.017 ↗
23. Fabrication of doxycycline-loaded electrospun PCL/PEO membranes for a potential drug delivery system10.1016/j.ijpharm.2019.04.073 ↗
24. Beaded nanofibers formed during electrospinning10.1016/S0032-3861(99)00068-3 ↗
25. Understanding drug release data through thermodynamic analysis10.3390/ma10060651 ↗
26. Electrospinning jets and nanofibrous structures10.1063/1.3567097 ↗
27. Fabrication and characterization of polymer-ceramic nanocomposites containing drug loaded modified halloysite nanotubes10.1002/jbm.a.36327 ↗
28. Nanoparticles and nanofibers for topical drug delivery10.1016/j.jconrel.2015.10.049 ↗
29. A comprehensive review summarizing the effect of electrospinning parameters and potential applications of nanofibers in biomedical and biotechnology10.1016/j.arabjc.2015.11.015 ↗
30. Enhanced drug delivery, mechanical properties and antimicrobial activities in poly(lactic acid) nanofiber with mesoporous Fe3O4-COOH nanoparticles10.1016/j.colsurfa.2018.09.012 ↗
31. Electrospun PLA: PCL composites embedded with unmodified and 3-aminopropyltriethoxysilane (ASP) modified halloysite nanotubes (HNT)10.1007/s00339-012-7233-7 ↗
32. Cellulose–halloysite nanotube composite hydrogels for curcumin delivery10.1007/s10570-017-1316-8 ↗
33. Porous carbon nanofibers from electrospun polyacrylonitrile/SiO2 composites as an energy storage material
34. Curcumin-loaded mixed micelles: preparation, characterization, and in vitro antitumor activity10.1155/2018/9103120 ↗
35. Preparation and characterization of electrospun poly(ε-caprolactone)/poly(vinyl pyrrolidone) nanofiber composites containing silver particles10.1002/pc.23481 ↗
36. Recent advances in electrospun polycaprolactone based scaffolds for wound healing and skin bioengineering applications10.1016/j.mtcomm.2019.02.009 ↗
37. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: in vitro and in vivo study10.1016/j.colsurfb.2016.09.044 ↗
38. Beneficial effect of Curcumin Nanoparticles-Hydrogel on excisional skin wound healing in type-I diabetic rat: Histological and immunohistochemical studies10.1016/j.aanat.2018.11.005 ↗
39. Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer10.1016/j.biomaterials.2019.04.005 ↗
40. The effect of halloysite modification combined with in situ matrix modifications on the structure and properties of polypropylene/halloysite nanocomposites10.3144/expresspolymlett.2013.43 ↗
41. Polymer microneedles fabricated from PCL and PCL/PEG blends for transdermal delivery of hydrophilic compounds10.1016/j.jtice.2015.01.003 ↗
42. Development of silane grafted halloysite nanotube reinforced polylactide nanocomposites for the enhancement of mechanical, thermal and dynamic-mechanical properties10.1016/j.clay.2016.10.046 ↗
43. Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue10.1186/1477-3155-12-10 ↗
44. Dendrimer-functionalized halloysite nanotubes for effective drug delivery10.1016/j.clay.2017.12.019 ↗
45. Biocompatibility and drug release behavior of curcumin conjugated gold nanoparticles from aminosilane-functionalized electrospun poly(N-vinyl-2-pyrrolidone) fibers10.1016/j.ijpharm.2016.10.067 ↗
46. Preparation and characterization of electrospun alginate nanofibers loaded with ciprofloxacin hydrochloride10.1016/j.eurpolymj.2017.09.020 ↗
47. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: Accelerated versus simulated physiological conditions10.1088/1748-6041/3/3/034108 ↗
48. Characterisation of halloysite for use as a microtubular drug delivery system10.1016/S0378-5173(02)00274-0 ↗
49. Higher quality quercetin sustained release ethyl cellulose nanofibers fabricated using a spinneret with a Teflon nozzle10.1016/j.colsurfb.2013.10.040 ↗
50. The combination of adsorption by functionalized halloysite nanotubes and encapsulation by polyelectrolyte coatings for sustained drug delivery
51. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms10.1021/acs.molpharmaceut.7b00319 ↗
52. Halloysite nanotubes and Fe 3 O 4 nanoparticles enhanced adsorption removal of heavy metal using electrospun membranes
53. Oral bioavailability of curcumin: problems and advancements10.3109/1061186X.2016.1157883 ↗
54. Curcumin inhibits MCF-7 cells by modulating the NF-κB signaling pathway
55. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models10.1016/j.jconrel.2019.04.014 ↗
56. Functionalization of carbon nanotubes using a silane coupling agent10.1016/j.carbon.2006.06.032 ↗
57. Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin10.1002/jbm.a.31584 ↗
58. PCL and PCL-based materials in biomedical applications10.1080/09205063.2017.1394711 ↗
59. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo10.1111/cas.13897 ↗
60. Chemical modification of halloysite nanotubes for controlled loading and release10.1039/C8TB00543E ↗
61. Comparative study of the properties of sericin-gelatin nanofibrous wound dressing containing halloysite nanotubes loaded with zinc and copper ions
62. Melda Eskitoros-Togay · 2018
63. Fabrication and characterization of three-dimensional nanofiber membrance of PCL-MWCNTs by electrospinning10.1016/j.msec.2010.05.003 ↗
64. Antioxidant and anti-inflammatory properties of curcumin10.1007/978-0-387-46401-5_3 ↗
65. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation10.1016/j.biomaterials.2010.04.062 ↗
66. Discovery of a new function of curcumin which enhances its anticancer therapeutic potency10.1038/srep30962 ↗
67. The Essential Medicinal Chemistry of Curcumin10.1021/acs.jmedchem.6b00975 ↗
68. Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma10.1016/j.colsurfb.2018.08.027 ↗
69. In vitro evaluation of electrospun PCL/nanoclay composite scaffold for bone tissue engineering10.1007/s10856-012-4647-x ↗
70. Structural and morphological characterization of micro and nanofibers produced by electrospinning and solution blow spinning: a comparative study10.1155/2013/409572 ↗
71. Enhanced dispersibility and bioactivity of curcumin by encapsulation in casein nanocapsules10.1021/jf400752a ↗
72. Microstructure and mechanical properties of thermoplastic elastomer nanocomposites based on PA6/NBR/HNT10.1002/pc.23936 ↗
73. Effect of halloysite nanotube structure on physical, chemical, structural and biological properties of elastic polycaprolactone/gelatin nanofibers for wound healing applications10.1016/j.msec.2018.05.033 ↗
74. Critical attributes of nanofibers: Preparation, drug loading, and tissue regeneration10.1016/j.ijpharm.2015.02.043 ↗
75. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice10.4143/crt.2014.46.1.2 ↗
76. Controlled release and antibacterial activity of antibiotic-loaded electrospun halloysite/poly(lactic-co-glycolic acid) composite nanofibers10.1016/j.colsurfb.2013.04.036 ↗
77. The preosteoblast response of electrospinning PLGA/PCL nanofibers: Effects of biomimetic architecture and collagen I10.2147/IJN.S110577 ↗
78. Development and characterization of amorphous nanofiber drug dispersions prepared using pressurized gyration10.1021/acs.molpharmaceut.5b00127 ↗
79. Ramalingam · 2017
80. Preparation and characterization of electrospun curcumin loaded poly(2-hydroxyethyl methacrylate) nanofiber-A biomaterial for multidrug resistant organisms10.1002/jbm.a.35138 ↗
81. Interaction and release kinetics study of hybrid polymer blend nanoparticles for pH independent controlled release of an anti-viral drug10.1016/j.jtice.2014.12.036 ↗
82. Rane · 2013
83. Electrospun curcumin loaded poly(ε-caprolactone)/gum tragacanth nanofibers for biomedical application10.1016/j.ijbiomac.2015.12.024 ↗
84. Preparation, characterization, and in vitro diffusion study of nonwoven electrospun nanofiber of curcumin-loaded cellulose acetate phthalate polymer10.1016/j.jsps.2017.02.004 ↗
85. Development of a novel ‘nanocarrier’ system based on Halloysite Nanotubes to overcome the complexation of ciprofloxacin with iron: an in vitro approach10.1016/j.clay.2017.10.002 ↗
86. “Nano in micro” architecture composite membranes for controlled drug delivery
87. A study on the release kinetics and mechanisms of vanillin incorporated in almond gum/polyvinyl alcohol composite nanofibers in different aqueous food simulants and simulated saliva10.1002/ffj.3335 ↗
88. Functional aliphatic polyesters for biomedical and pharmaceutical applications10.1016/j.jconrel.2010.12.016 ↗
89. Fabrication of curcumin-loaded electrospun nanofiberous polyurethanes with anti-bacterial activity
90. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides10.1186/1556-276X-6-608 ↗
91. Controlled release of a hydrophilic drug from coaxially electrospun polycaprolactone nanofibers10.1016/j.ijpharm.2016.03.032 ↗
92. Effective activation of halloysite nanotubes by piranha solution for amine modification via silane coupling chemistry
93. Natural halloysite nanotubes as mesoporous carriers for the loading of ibuprofen10.1016/j.micromeso.2013.05.007 ↗
94. Loading and in vitro release of ibuprofen in tubular halloysite10.1016/j.clay.2014.01.018 ↗
95. Processing of polycaprolactone porous structure for scaffold development10.1016/j.jmatprotec.2006.07.016 ↗
96. Electrospun polymeric nanofibers: new horizons in drug delivery10.1016/j.ejps.2017.07.001 ↗
97. Simple criterion for stability of aqueous suspensions of ultrafine particles of a poorly water soluble drug10.1021/la500825j ↗
98. A review of curcumin and its derivatives as anticancer agents10.3390/ijms20051033 ↗
99. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability10.1016/S0378-5173(02)00323-X ↗
100. Enhanced hydrophilicity and mechanical robustness of polysulfone nanofiber membranes by addition of polyethyleneimine and Al 2 O 3 nanoparticles10.1016/j.seppur.2017.06.047 ↗